tctmd -- A small study linking previous aspirin therapy with lower thrombus burden in patients undergoing primary percutaneous coronary intervention (PCI) shows the potential mechanism by which the antiplatelet drug may prevent or lessen the damage of an ST-segment elevation myocardial infarction (STEMI), according to findings published online January 25, 2010, ahead of print in the American Journal of Cardiology.
